Also in serum, both the methylation in promoters of protocadherin 17 (PCDH17) and protocadherin-10 (PCDH10) showed an association with BC poor prognosis (Lin et al., 2012; Luo et al., 2014). This evidence concerns the gene PCDH17 and breast cancer.